Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors

R Leira, A Davalos, Y Silva, A Gil-Peralta, J Tejada… - Neurology, 2004 - AAN Enterprises
Objective: To identify potential predictors of and factors associated with early neurologic
deterioration (END) in primary intracerebral hemorrhage (ICH). Methods: Two hundred sixty-six …

Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages

…, R Leira, J Tejada, A Gil-Peralta… - Journal of Neurology …, 2005 - jnnp.bmj.com
Objective: To determine potential predictors of good outcome in primary medium to large
intracerebral haemorrhages (ICH) which could be useful for selecting patients for surgical …

Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial

…, A Rosell, MD Jimenez, A Mayol, A Gil-Peralta - Stroke, 2012 - Am Heart Assoc
Background and Purpose— Bone marrow mononuclear cell (BM-MNC) intra-arterial
transplantation improves recovery in experimental models of ischemic stroke. We aimed to assess …

Percutaneous transluminal angioplasty of the symptomatic atherosclerotic carotid arteries: results, complications, and follow-up

A Gil-Peralta, A Mayol, JRG Marcos, A Gonzalez… - Stroke, 1996 - Am Heart Assoc
Background and Purpose Carotid endarterectomy reduces stroke risk in patients with >70%
symptomatic stenosis. We present our results of percutaneous transluminal angioplasty (PTA…

Peripheral arterial disease in patients with stages IV and V chronic renal failure

…, R Montes, J Muñoz-Terol, A Gil-Peralta… - Nephrology Dialysis …, 2006 - academic.oup.com
Background. Cardiovascular disorders are frequently found among chronic renal failure (CRF)
patients due to their higher susceptibility to develop atherosclerosis. However, peripheral …

The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin …

…, K Spengos, A González, A Gil-Peralta… - Cerebrovascular …, 2002 - karger.com
The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International,
Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in …

Silent ischemia after neuroprotected percutaneous carotid stenting: a diffusion-weighted MRI study

…, F Boza, A Cayuela, A Gil-Peralta - American Journal …, 2006 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: To assess by diffusion-weighted MR imaging (DWI) the
efficacy of cerebral protection devices in avoiding embolization and new ischemic lesions in …

Stroke in the Lehigh Valley: racial/ethnic differences

…, SM Lai, M Alter, E Sobel, L LaRue, A Gil-Peralta… - Neurology, 1989 - AAN Enterprises
We investigated black/white differences in stroke rate (standardized morbidity), severity, and
subtype, and the relative frequencies of 5 primary risk factors (hypertension, diabetes, …

Internal carotid artery stenting in patients with near occlusion: 30-day and long-term outcome

A González, A Gil-Peralta, A Mayol… - American Journal …, 2011 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: The natural history of the carotid NO is poorly characterized,
and the management of patients remains controversial. We report the results and …

Cerebral hemodynamic changes after carotid angioplasty and stenting

…, E Franco-Macias, A Gil-Peralta - American journal …, 2007 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Carotid angioplasty stent placement (CAS) is an accepted
alternative to endarterectomy. However, little is known about its effect on cerebral …